Browsing: Clinical Trials

Pfizer is the latest big pharmaceutical company turning to China for biotechnology innovation, striking up a cancer R&D agreement spanning…

Apogee Therapeutics’ lead drug candidate has new mid-stage data indicating it could be competitive with currently available biologic medicines for…

Triomics, a startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks like clinical trial matching…

Many of Eli Lilly’s acquisitions this year double down in areas where the company is already a player, such as…

A Daiichi Sankyo and AstraZeneca drug is now approved as a first-line treatment for a particularly difficult-to-treat type of breast…

Clinical trials are powered by people: patients who volunteer, and site teams who sustain them. Yet the modern trial increasingly…

Next-generation obesity drugs are testing combination approaches intended to lead to greater weight reduction and one of them, an experimental…

The clinical trial industry spent the better part of the last decade solving a proximity problem. If patients couldn’t —…

A BioMarin Pharmaceutical deal last year brought the company a late-stage therapy that fit the company’s extensive enzyme replacement experience…

Despite the availability of many hypertension drugs, many people find these medicines don’t work well enough. A first-in-class AstraZeneca medication…